Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2025 10:04 ET | Source: ADvantage Therapeutics, Inc.

Klothea Bio Collaborates with Healthy Longevity Clinic, a Top 40 Semifinalist in $101 million XPRIZE Healthspan Competition

MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- Klothea Bio Inc., a biotechnology company pioneering mRNA-based therapies to upregulate the anti-aging protein Klotho, today announced its ongoing...
November 25, 2024 09:41 ET | Source: ADvantage Therapeutics, Inc.

Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics

MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Advantage Therapeutics Inc., a leader in developing therapies targeting age-related diseases, announced today the formation of its new subsidiary, Klothea...
September 09, 2024 10:01 ET | Source: ADvantage Therapeutics, Inc.

ADvantage Therapeutics, Inc. Welcomes Dr. William A. Haseltine as Strategic Advisor to Drive Innovation in Alzheimer's Disease Research and Anti-aging Therapies such as Klotho Protein Supplementation to Extend Healthy Human Lifespan

MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a leading clinical-stage biotechnology company dedicated to the advancement of innovative therapies for Alzheimer's disease,...
February 05, 2024 09:41 ET | Source: Advantage Therapeutics Inc.

Discoverer of the Klotho Gene and Pioneer in Longevity and Disease Prevention Dr. Makoto Kuro-o Joins Scientific Advisory Board of ADvantage Therapeutics

BOCA RATON, Fla. and VIENNA, Austria, Feb. 05, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, a pioneer in developing therapies for neurodegenerative conditions by addressing the biology of aging,...
April 14, 2023 07:00 ET | Source: Guardian Capital LP

Guardian Capital Announces April 2023 Distributions for Guardian Capital ETFs

TORONTO, April 14, 2023 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending April 30, 2023, in respect of the ETF series of the Guardian...
March 24, 2023 08:45 ET | Source: Advantage Therapeutics Inc.

Renowned Public Health Advisor Jim O’Neill Joins Board of Directors of ADvantage Therapeutics

BOCA RATON, Fla. and VIENNA, Austria, March 24, 2023 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), which is developing therapies to treat neurodegenerative...
September 07, 2022 07:00 ET | Source: Guardian Capital LP

Guardian Capital LP vise à révolutionner la retraite au moyen de solutions novatrices, y compris une tontine unique et moderne

Les solutions de longévité ParcoursGardéMC créées en partenariat avec le professeur Moshe A. Milevsky, PhD, sont conçues pour résoudre ce que l’économiste lauréat du prix Nobel William Sharpe a décrit...
September 07, 2022 07:00 ET | Source: Guardian Capital LP

Guardian Capital LP aims to revolutionize retirement with first-of-their-kind solutions, including a uniquely modern tontine

GuardPath™ Longevity Solutions, created in partnership with Professor Moshe A. Milevsky, PhD, are designed to address what Nobel Laureate Economist William Sharpe has described as the “nastiest,...
April 07, 2022 09:00 ET | Source: Florasophy

Florasophy Weighs Fiber as Medicine

Portland, Oregon, April 07, 2022 (GLOBE NEWSWIRE) -- PORTLAND, OR., April 7, 2022 — Florasophy, a collection of organic, clinician-developed soluble fiber blends, has launched in Portland, Oregon....
December 17, 2020 07:00 ET | Source: Guardian Capital LP

Guardian Capital Announces December 2020 Distributions for Guardian Capital ETFs

TORONTO, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Guardian Capital LP announces the following regular cash distributions for the period ending December 31, 2020, in respect of the Guardian Capital ETFs...

Next Page keyboard_arrow_right